Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors

被引：0
作者：
Chen, Po-Han [1 ]
Bossuyt, Veerle [2 ]
Reisenbichler, Emily [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
[2] Massachusetts Gen Hosp, Woodbridge, CT USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
123
引用
收藏
页数：2
相关论文
共 50 条
[1]   Lymphoid Enhancer Binding Factor 1 (LEF1) as a Biomarker for Wnt/Beta-Catenin Pathway Activation in the Biological Progression of Phyllodes Tumors [J].
Chen, Po-Han ;
Bossuyt, Veerle ;
Reisenbichler, Emily .
MODERN PATHOLOGY, 2019, 32
[2]   Lymphoid enhancer-binding factor 1 (LEF1) immunostaining as a surrogate for β-catenin (CTNNB1) mutations [J].
Hewer, Ekkehard ;
Fischer, Pascal David ;
Vassella, Erik ;
Knabben, Laura ;
Imboden, Sara ;
Mueller, Michael D. ;
Rau, Tilman T. ;
Dettmer, Matthias S. .
JOURNAL OF CLINICAL PATHOLOGY, 2024,
[3]   WNT1 Pathway (Beta-Catenin and LEF1) Immunohistochemical Staining Patterns in Hepatoblastoma and Common Differentials-Assessing the Diagnostic Utility of LEF1 Staining [J].
Gardner, Dominique ;
Adkins, Jesse ;
Koo, Selene .
LABORATORY INVESTIGATION, 2025, 105 (03)
[4]   LYMPHOID ENHANCER-BINDING FACTOR 1 (LEF1): AN IMMUNOHISTOCHEMICAL PREDICTIVE MARKER FOR WNT-ACTIVATED MEDULLOBLASTOMA [J].
Ranade, Manali ;
Naik, Khushi ;
Bapat, Prachi ;
Gurav, Mamta ;
Shetty, Omshree ;
Shah, Aekta ;
Sahay, Ayushi ;
Prasad, Maya ;
Singh, Vikash ;
Shetty, Prakash ;
Moiyadi, Aliasgar ;
Dasgupta, Archya ;
Chatterjee, Abhishek ;
Chinnaswamy, Girish ;
Gupta, Tejpal ;
Epari, Sridhar .
NEURO-ONCOLOGY, 2024, 26
[5]   Diagnostic utility of LEF1 and β-catenin in WNT pathway tumors with CTNNB1 mutation [J].
Li, Can ;
Dong, Lingdan ;
Zhu, Li ;
Guan, Wenbin .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2025, 23 (01)
[6]   Submucosal gland development in the airway is controlled by Lymphoid Enhancer Binding Factor 1 (LEF1) [J].
Duan, DS ;
Yue, YP ;
Zhou, WH ;
Lebed, B ;
Ritchie, TC ;
Grosschedl, R ;
Engelhardt, JF .
DEVELOPMENT, 1999, 126 (20) :4441-4453
[7]   Lymphoid enhancer-binding factor 1 (LEF1): a reliable immunohistochemical predictive marker for WNT-activated medulloblastoma [J].
Ranade, Manali ;
Epari, Sridhar ;
Gurav, Mamta ;
Sahay, Ayushi ;
Shetty, Prakash ;
Prasad, Maya ;
Gupta, Tejpal ;
Chinnaswamy, Girish .
CHILDS NERVOUS SYSTEM, 2025, 41 (01)
[8]   Wnt signaling regulates lymphoid enhancer factor (Lef-1) isoform expression through functional interactions between PITX2, beta-catenin and Lef-1 [J].
Amendt, Brad A. ;
Liu, Xiaoming ;
Amen, Melanie ;
Engelhardt, John F. .
FASEB JOURNAL, 2007, 21 (05) :A656-A656
[9]   ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway [J].
Ding, Yang ;
Ning, Yumei ;
Kang, Hui ;
Yuan, Yuan ;
Lin, Kun ;
Wang, Chun ;
Yi, Yun ;
He, Jianghua ;
Li, Lurao ;
He, Xingxing ;
Chang, Ying .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
[10]   ZMIZ2 facilitates hepatocellular carcinoma progression via LEF1 mediated activation of Wnt/β-catenin pathway [J].
Yang Ding ;
Yumei Ning ;
Hui Kang ;
Yuan Yuan ;
Kun Lin ;
Chun Wang ;
Yun Yi ;
Jianghua He ;
Lurao Li ;
Xingxing He ;
Ying Chang .
Experimental Hematology & Oncology, 13
12345